View More Recent Stories

Aug 22, 2016 04:33PM BioStem Technologies, Inc. (OTC Pink: BSEM) Acquires Their First FDA Approved Branded Generic Drug (ANDA) -- Granisol(R) Oral Solution
Aug 16, 2016 11:12AM BioStem Technologies, Inc. (OTC Pink: BSEM) Engages American Capital Ventures for Investor Relations Services
Jul 13, 2016 09:53AM BioStem Technologies, Inc. (OTC Pink: BSEM) Begins Construction of New Laboratory Facility
Jun 2, 2016 09:30AM BioStem Technologies, Inc. (OTC: BSEM) Announces Issuance of FDA Drug Establishment Registration Number and FDA Labeler Code to Wholly Owned Subsidiary BioStem Pharmaceuticals, Inc.
May 27, 2016 10:30AM BioStem Technologies, Inc. (OTC: BSEM) Appoints David Wolfe and Dr. Michael Beckwith to Its Advisory Board
May 26, 2016 06:41PM BioStem Technologies, Inc. (OTC PINK: BSEM) Completes Capital Restructuring Initiatives
May 25, 2016 05:28PM BioStem Technologies, Inc. (OTC Pink: BSEM) Acquires TEN(R) Health Behavior Change Platform
Mar 18, 2016 02:46PM BioStem Technologies, Inc. (OTC: BSEM) Appoints New Members to Its Board of Directors
Mar 16, 2016 02:41PM BioStem Technologies Inc. (OTC: BSEM) Receives Prestigious 2016 Best of Oakland Park Award
Feb 24, 2016 05:45PM MULTIMEDIA UPDATE: Biostem Technologies, Inc. (OTC: BSEM) Signs 98-Acre Land Acquisition Contract in Iceland
Feb 24, 2016 04:06PM Biostem Technologies, Inc. (OTC: BSEM) Signs 98-Acre Land Acquisition Contract in Iceland
Feb 1, 2016 12:18PM Biostem Technologies, Inc. (OTC: BSEM) Announces the Appointment of Dr. Dave Woynarowski as Chief Medical Officer
Jan 28, 2016 09:30AM Biostem Technologies, Inc. (OTC: BSEM) Announces Commencement of International Operations in Guadalajara, Mexico
View More Recent Stories